STAA News and Press, STAAR Surgical Company From 12/19/22

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that President and Chief Executive Officer Caren Mason will be retiring December 31, 2022, after leading the company through a significant period of revitalizat...

Facility Now Serves as a Dynamic Hub of the EVO Lens-Based Experience for Ophthalmic Surgeons, Staff and Healthcare Practitioners STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced the open...

STAAR Surgical Company (STAA) Q3 2022 Earnings Conference Call November 2, 2022 16:30 ET Company Participants Brian Moore - Vice President, Investor, Media Relations and Corporate Development Caren Mason - President and Chief Executive Officer Patrick Williams - ...

STAAR Surgical press release ( NASDAQ: STAA ): Q3 Non-GAAP EPS of $0.38 beats by $0.17 . Revenue of $76.05M (+30.3% Y/Y) beats by $1.1M . ICL Sales of $72M, +33% Y/Y. CEO comment: Despite stringent COVID policies in China we achieved strong result...

ICL Units Up 40% Y/Y; Constant Currency Net Sales of $80.0 Million STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter e...

STAAR Surgical ( NASDAQ: STAA ) is scheduled to announce Q3 earnings results on Wednesday, November 2nd, after market close. The consensus EPS Estimate is $0.21 (flat Y/Y) and the consensus Revenue Estimate is $74.95M (+28.4% Y/Y). Over the last 2 years, STAA has bea...

Summary Baillie Gifford’s 13F portfolio value decreased from ~$97.51B to ~$96.99B this quarter. They increased Shopify, Roblox, Zoom Video, and Twilio while reducing Albemarle Corporation and Li Auto ADR. The top three positions are Tesla Motors, Moderna, and MercadoLib...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended September 30, 2022 on Wednesday, Novembe...

More than 2 Billion People Suffer from Myopia (Nearsightedness) Globally 1 ; Max Strus Teams Up with STAAR Surgical to Inspire Athletes of All Levels and Others to Take a Shot at Visual Freedom STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer ...

Summary STAAR Surgical continues to demonstrate the fundamental equity premia investors are seeking out in FY22. The buy thesis remains intact from previous analysis on STAA in our estimate and here I've gone over the company's latest numbers. I've made no changes to the $98 p...